NCT06865079: 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
- State
- Under way
- Phase
- Phase 2
- People
- 270 planned
- Started
- 9 May 2025
- Primary completion
- 25 Mar 2027
- Arms
- TPX-100 (200 mg per dose)
- Results
- None posted
- 7 Mar 2025: Trial registered
- 9 May 2025: Trial started